MoneyWorks4Me

The Total revenue for the quarter ended September 2022 of  Rs. 5414.10 millions remain, more or less, the same.The Net Profit of the company slipped to Rs. 156.70 millions from Rs. 308.40 millions, a decline of -49.19% on QoQ basis.Operating Profit reported a sharp decline to 367.30 millions from 543.10 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 5414.10 5378.80 0.66 11064.20 10563.90 4.74 21840.20 19669.80 11.03
Other Income 50.60 105.10 -51.86 102.10 162.30 -37.09 320.40 243.00 31.85
PBIDT 367.30 543.10 -32.37 979.00 1701.80 -42.47 2883.20 6161.40 -53.21
Interest 35.10 18.90 85.71 68.90 36.60 88.25 82.90 58.30 42.20
PBDT 332.20 524.20 -36.63 910.10 1525.90 -40.36 2661.00 6103.10 -56.40
Depreciation 113.20 108.00 4.81 223.00 211.20 5.59 432.60 389.20 11.15
PBT 219.00 416.20 -47.38 687.10 1314.70 -47.74 2228.40 5713.90 -61.00
TAX 62.30 107.80 -42.21 181.50 336.30 -46.03 571.80 1268.30 -54.92
Deferred Tax 5.40 3.30 63.64 3.00 -2.90 -203.45 1.70 -187.20 -100.91
PAT 156.70 308.40 -49.19 505.60 978.40 -48.32 1656.60 4445.60 -62.74
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 6.78 10.10 -32.81 8.85 16.11 -45.07 13.20 31.32 -57.86
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..